PCN113 Cost-Utility Analysis of Combination Therapy of Pegylated Liposomal Doxorubicin(PLD) and Carboplatin for Korean Women with Platinum-Sensitive Ovarian Cancer
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1214
https://www.valueinhealthjournal.com/article/S1098-3015(11)02776-8/fulltext
Title :
PCN113 Cost-Utility Analysis of Combination Therapy of Pegylated Liposomal Doxorubicin(PLD) and Carboplatin for Korean Women with Platinum-Sensitive Ovarian Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02776-8&doi=10.1016/j.jval.2011.08.1214
First page :
A455
Section Title :
Cancer
Open access? :
No
Section Order :
1172